Key result
HIV on antiretroviral therapy is linked to earlier and higher rates of cardiovascular disease.
Answers are grounded in this paper and cite their sources.
In the more than 30 years since AIDS was first recognized, there has been a sea change in the challenges facing human immunodeficiency virus (HIV)-infected patients and their caregivers.Now that antiretroviral therapy (ART) suppresses viral replication and prevents AIDS-related complications in the majority of HIVinfected patients [1], different clinical problems from those faced in the first decades of the epidemic have emerged.In particular, chronic conditions typical of aging, including cardiovascular disease, diabetes, bone fractures, and malignancies, are occurring in HIVinfected patients at a higher rate and at an earlier age than in uninfected individuals [2].To provide an overview of the current state of our knowledge and a guide to future approaches for meeting these challenges, the Harvard University Center for AIDS Research organized a multidisciplinary symposium on metabolic and cardiovascular complications in HIVinfected patients; this supplement is an outgrowth of presentations made at that symposium.Among the most important clinical problems facing HIV-infected patients is a rising rate of cardiovascular disease.The World Health Organization projects that ischemic heart disease will be the leading cause of death in the general population in both low-and high-income
No takes yet. Share an insight, caveat, or question.
Gandhi et al. (2012) conducted an editorial in HIV infection with metabolic and cardiovascular complications. HIV-infected patients on antiretroviral therapy experience chronic aging conditions, including cardiovascular disease and diabetes, at higher rates and earlier ages than uninfected individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: